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Abstract
E-cadherin and cadherin-11 are two members of the cadherin gene family of cell adhesion molecules that are differentially expressed
during the aggregation, differentiation, and fusion of trophoblasts isolated from the human term placenta. E-cadherin expression is highest
in cytotrophoblasts and decreases as these mononucleate cells undergo terminal differentiation and fusion. In contrast, cadherin-11
expression increases during the formation of multinucleated syncytium in these primary cultures. To define the role(s) of cadherin-11 in this
developmental process, we examined the effects of ectopic cadherin-11 expression on the differentiation and fusion of JEG-3 choriocar-
cinoma cells, a mononucleate trophoblastic cell line. Cadherin-11 expression, but not the ectopic expression of the related cadherin subtype,
cadherin-6, resulted in the formation of multinucleated syncytium in the transfected JEG-3 cell cultures. Multinucleated syncytium
formation in the JEG-3 cells transfected with cadherin-11 was associated with a reduction in E-cadherin, -, -, -catenin, and p120ctn
expression. Cadherin-11 also reduced cell proliferation and increased the levels of the mRNA transcript encoding the beta subunit of human
chorionic gonadotropin, a biochemical marker of trophoblast differentiation, in these cultures. Furthermore, primary cytotrophoblasts
cultured in the presence of antisense oligonucleotides specific for cadherin-11 maintained E-cadherin expression and did not undergo
terminal differentiation and fusion with time in culture. Collectively, these observations demonstrate that cadherin-11 contributes to the
morphological and functional differentiation of cultured mononucleate trophoblastic cells in a highly specific manner.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The cadherins are a gene superfamily of integral mem-
brane glycoproteins that mediate calcium-dependent ho-
mophilic cell adhesion (Takeichi, 1995; Suzuki, 1996). This
gene superfamily has been divided into at least two distinct
subfamilies: type 1 and type 2 classical cadherins. The type
1 cadherins include R-cadherin, also known as cadherin-4,
and the three originally identified cadherins, E-cadherin
(E-cad), N-cadherin (N-cad), and P-cadherin, whereas hu-
man cadherin-6, -7, -8, -9, -10, -11, -12, -14, -18, -19, and
-20 have been assigned to the type 2 cadherin subfamily
(Nollet et al., 2000; Yagi and Takeichi, 2000).
The type 1 and type 2 classical cadherins share common
structural features (Suzuki et al., 1991; Tanihara et al.,
1994). Although the overall amino acid sequence homology
between these two subfamilies is low, the cytoplasmic do-
mains of the type 1 and type 2 cadherins are highly con-
served (Suzuki et al., 1991). These domains interact with a
group of proteins, known as the catenins. -Catenin and
-catenin (also known as plakoglobin) interact with the
cadherins in a mutually exclusive manner (Butz and Kem-
ler, 1994; Nathke et al., 1994). -Catenin, in turn, links both
cadherin-catenin complexes to the actin-based cytoskeleton
by direct interaction (Rimm et al., 1995) or via -actinin
(Knudsen et al., 1995). p120ctn, a substrate for the Src
tyrosine kinases, has also been shown to interact with the
cadherin cytoplasmic domain at a different site from that of
- or -catenin (Reynolds et al., 1989, 1992; Ohkubo and
Ozawa, 1999). The binding of the catenins to the cadherin
cytoplasmic tail is believed to alter the strength of cadherin-
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based adhesion complexes (Brieher et al., 1996; Ozawa and
Kemler, 1998).
The cadherins are key morphoregulators (Takeichi,
1995, Tepass et al., 2000). The spatiotemporal expression of
both the type 1 and type 2 classical cadherins is tightly
regulated during embryonic development. For example, the
differential expression of E-cad and cadherin-11 (cad-11)
has been associated with the formation of mesodermal cell
layers in the rodent embryo (Hoffmann and Balling, 1995;
Simonneau et al., 1995). The regulated expression of the
type 1 cadherins has also been shown to govern the devel-
opmental fate of cells. In particular, the transfection of a
full-length E-cad cDNA into embryonic stem cells lacking
endogenous cadherin expression results in epithelial cell
differentiation, whereas N-cad expression promotes the for-
mation of cartilage and neuroepithelial cell structures (La-
rue et al., 1996). To date, the ability of the type 2 cadherins
to modulate cellular differentiation remains poorly charac-
terized.
Villous cytotrophoblasts of the human placenta undergo
cellular differentiation and fusion to form the syncytial
trophoblast, a multinucleated cell that contributes to the
majority of placental transport, immunoregulatory, and en-
docrine functions during pregnancy (Richart, 1961; Kliman
et al., 1986). We have determined that E-cad and cad-11 are
differentially expressed during the terminal differentiation
and fusion of mononucleate villous cytotrophoblasts iso-
lated from the human term placenta (MacCalman et al.,
1996). In particular, E-cad expression levels are high in
freshly isolated cytotrophoblasts and decrease as the cells
undergo aggregation and fusion to form multinucleated syn-
cytium with time in culture. The loss of E-cad expression
during this cellular event was concomitant with a marked
increase in the expression levels of cad-11. The formation of
multinucleated syncytium in these cell cultures also corre-
lates with a marked reduction in the expression levels of -,
-, -catenin and p120ctn (Getsios et al., 2001). In contrast,
E-cad and these four catenin subtypes, but not cad-11, are
readily detectable in nonfusing JEG-3 choriocarcinoma
cells. Collectively, these observations have led us to hy-
pothesize that cad-11 mediates the formation of multinucle-
ated syncytium from mononucleate trophoblastic cells in
vitro.
Here, we report that the exogenous expression of cad-11,
but not cadherin-6 (cad-6), in mononucleate JEG-3 cells is
capable of promoting the morphological and functional dif-
ferentiation of these trophoblastic cells. The formation of
multinucleated syncytium in these transiently transfected
cells correlated with a reduction in the expression levels of
E-cad and -, -, -catenin and p120ctn. Antisense oligo-
nucleotides specific for cad-11 inhibited the terminal differ-
entiation and fusion of villous cytotrophoblasts isolated
from the human term placenta. Collectively, we believe that
these observations add to our understanding of the adhesive




Term placentae were obtained from women undergoing
Caesarian section. Follicular aspirates were collected from
the ovaries of patients undergoing in vitro fertilization and
embryo transfer. Research using these human tissues was
approved by the Committee for Ethical Review of Research
Involving Human Subjects, University of British Columbia.
All subjects provided informed written consent.
Cell isolation and culture
Granulosa-lutein cells were isolated from human ovarian
follicles according to the methods described by Golos and
Strauss (1987). Briefly, the follicular aspirates were centri-
fuged on a Ficoll-Paque gradient (Pharmacia Biotech Inc.,
Baie D’Urfe, PQ) at 1000g for 10 min at room temperature.
The granulosa-lutein cells were collected from the gradient
interface before being washed, resuspended, and plated in
Dulbecco’s modified Eagle’s medium (Gibco BRL, Burl-
ington, ON) containing 25 mM glucose, 25 mM Hepes, and
50 g/ml gentamicin and supplemented with 10% heat-
inactivated fetal bovine serum (Hyclone Labs Inc., Logan,
UT).
Villous cytotrophoblasts were isolated from human term
placental tissues as previously described by Kliman et al.
(1986). This method, which utilizes serial trypsin–DNase I
digestions, yields a highly enriched preparation of mono-
nucleate cytotrophoblasts. Following isolation, the cells
were resuspended and plated in the culture medium de-
scribed above. JEG-3 choriocarcinoma cells were obtained
from the American Type Culture Collection (Rockville,
MD) and maintained in the culture medium described
above.
Expression vectors
Full-length cad-11 or cad-6 cDNAs (gifts from ICOS
Corp., Bothell, WA) were subcloned into the NotI restric-
tion site of the mammalian expression vector, pCMV/
SPORT1 (Gibco BRL), using standard molecular biology
techniques. Clones containing the cad-11 or cad-6 cDNA in
the forward (pCAD-11 or pCAD-6) or reverse orientation
(pRCAD-11 or pRCAD-6) were identified by DNA se-
quence analysis. A pCMV/SPORT1 expression vector con-
taining the -galactosidase gene (placZ; Gibco BRL) was
used to determine transfection efficiency, whereas
pRCAD-6 and pRCAD-11 served as controls for these stud-
ies.
The ability of exogenous cad-11 expression to modulate
the morphological and functional differentiation of JEG-3
choriocarcinoma cells was then examined. JEG-3 cells (2.5
 105 cells) were seeded on glass coverslips (2 2 cm) and
cultured for 12 h. The cells were then transfected with
42 S. Getsios, C.D. MacCalman / Developmental Biology 257 (2003) 41–54
pCAD-11, pRCAD-11, or placZ (1.0 g/ml) by using the
Fugene 6 transfection reagent (Roche Diagnostics, Laval,
PQ) and cultured for a further 0, 12, 24, or 36 h.
Antisense oligonucleotides
Oligonucleotide sequences (18 mers, 50% AT/GC con-
tent) were selected from the full-length human cad-11
cDNA (GenBank Accession No. L34056.1) by using the
Primer3 program (Whitehead Institute, Cambridge, MA).
DNA sequences located near the 5 end of the cad-11 cDNA
were compared with the human sequence databases of
EMBL and GenBank. Two sequences were identified (5-
GGCGGCTTGTAAACAGTA-3 and 5-CACGAAGAAC-
TGGTTCCA-3), corresponding to bp 168–185 and bp
324–341 of the cad-11 cDNA, respectively. Phosphorothio-
ate-conjugated antisense oligonucleotides (OB-1 and OB-2)
complementary to these DNA sequences and the corre-
sponding sense oligonucleotides (OB-3 and OB-4) were
prepared (Nucleic Acid and Protein Synthesis Biotechnol-
ogy Lab, University of British Columbia, Vancouver, BC)
and used in these studies.
Granulosa-lutein cells, which express cad-6, cad-11, and
N-cad (MacCalman et al., 1997), were cultured in the pres-
ence of the antisense oligonucleotides, OB-1 or OB-2.
Granulosa-lutein cells (1  106 cells) were seeded in
60-mm culture dishes and cultured in the presence of in-
creasing concentrations (0, 1, or 5 M) of antisense (OB-1
or OB-2) or sense oligonucleotides (OB-3 or OB-4) for a
further 24 h. The concentrations of oligonucleotides used in
these experiments were selected on the basis of previous
studies (Caniggia et al., 1997).
The ability of these antisense oligonucleotides to inhibit
the terminal differentiation and fusion of villous cytotro-
phoblasts isolated from the human term placenta was then
examined. Mononucleate cytotrophoblasts (2  105 cells)
were seeded on glass coverslips (2  2 cm) and cultured in
the presence of OB-1 or OB-2 (5 M) for 24, 48, or 72 h.
Cytotrophoblasts cultured in the presence of the sense oli-
gonucleotides, OB-3 or OB-4 (5 M), served as a control
for these studies.
Northern blot analysis
Total RNA was prepared from cultures of granulosa-
lutein cells or JEG-3 cells by using the phenol-chloroform
method of Chomczynski and Sacchi (1987). The RNA spe-
cies were resolved by electrophoresis in 1% agarose gels
containing 3.7% formaldehyde. Approximately 20 g of
total RNA was loaded in each lane. The fractionated RNA
species were then transferred onto charged nylon mem-
branes (Amersham Canada Ltd., Oakville, ON).
The Northern blots were probed with radiolabeled
cDNAs specific for human cad-11 (MacCalman et al.,
1996), N-cad (MacCalman et al., 1997), cad-6 (Getsios et
al., 1998), the beta subunit of human chorionic gonadotro-
pin cDNA (hCG; Coutifaris et al., 1991), and a radiola-
beled synthetic oligonucleotide specific for 18S rRNA (Szyf
et al., 1990) as previously described (MacCalman et al.,
1992).
Antibodies
Two mouse monoclonal antibodies specific for human
cad-11 (113E and 113H) were used in these studies (gifts
from ICOS Corp., Bothell, WA). Mouse monoclonal anti-
bodies directed against human E-cad and the four catenin
subtypes, -, -, -catenin, and p120ctn, were purchased
from Transduction Labs (Lexington, KY). A goat poly-
clonal antibody directed against cad-6 was purchased from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), and a
rabbit polyclonal antibody directed against desmoplakin
(NW6; Angst et al., 1990) was kindly provided by Dr. K.J.
Green (Northwestern University, Chicago, IL). A mouse
monoclonal antibody directed against 5-bromo-2-deoxy-
uridine (BrdU) was purchased from Roche Diagnostics.
Nonspecific isotype-matched antibodies purchased from
Dako Corp. (Carpenteria, CA) were used as negative con-
trols in these studies.
Western blot analysis
Cultures of JEG-3 cells or villous cytotrophoblasts were
washed three times in PBS and incubated in 100 l of cell
lysis buffer (10 mM Tris–HCl, pH 7.5, containing 0.5%
Nonidet P-40, 0.5 mM CaCl2, and 1.0 mM PMSF) at 4°C
for 30 min on a rocking platform. The cell lysates were
centrifuged at 10,000g for 20 min, and the supernatants
were used for Western blot analysis. The concentration of
protein in the cell lysates was determined by using the BCA
kit (Pierce Chemicals, Rockford, IL). Western blots con-
taining aliquots (20 g) of the cell lysates were prepared
and immunoblotted as previously described (MacCalman et
al., 1996). The Amersham ECL system was used to detect
antibody bound to antigen.
Indirect immunofluorescence
Indirect immunofluorescence was performed by using
JEG-3 cells that had been plated on glass coverslips and
fixed in methanol at 20°C for 2 min. Coverslips were
incubated with primary antibodies for 45 min at 37°C.
Primary antibodies were detected by using Alexa Fluor
conjugated secondary antibodies (Molecular Probes, Eu-
gene, OR). JEG-3 cell nuclei were stained with 4,6-dia-
midino-2-phenylindole (DAPI; Sigma, St. Louis, MO). The
coverslips were examined by using a Leica DMR micro-
scope/Orca Hamamatsu system and analyzed with OpenLab
software (Improvision, Lexington, MA).
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Immunocytochemistry
Cultures of JEG-3 cells or villous cytotrophoblasts were
fixed in 2% paraformaldehyde/0.2% glutaraldehyde for 15
min at room temperature. Immunocytochemistry was per-
formed according to the methods of Cartun and Pedersen
(1989) and included sequential incubations in 10% normal
horse serum, primary antiserum at 37°C for 1 h, secondary
biotinylated antibody at 37°C for 45 min, streptavidin–
biotinylated horseradish peroxidase complex reagent at
37°C for 30 min, and three washes (5 min each) in PBS. The
cells were then exposed to chromagen reaction solution
(0.035% diaminobenzidine and 0.03% H2O2) for 10 min,
washed in tap water for 5 min, counterstained in hematox-
ylin, dehydrated, cleared, and mounted.
BrdU incorporation
A BrdU labeling and detection kit (BrdU labeling and
detection kit II; Roche Diagnostics) was used to determine
Fig. 1. Cadherin and catenin expression in JEG-3 choriocarcinoma cells transiently transfected with pCAD-11. Autoradiograms of Western blots containing
protein extracts (20 g) prepared from JEG-3 cells transfected with pCAD-11 for 0, 12, 24, or 36 h. Western blot analysis was performed by using mouse
monoclonal antibodies directed against human cad-11 (113H), E-cad, -, -, -catenin, or p120ctn (A–F, respectively). The relative electrophoretic mobilities
of the molecular weight markers are shown on the left-hand side of the immunoblots.
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the effects of ectopic cad-11 expression on JEG-3 cell
proliferation. Briefly, JEG-3 cells were cultured in the
presence of BrdU (10 M) prior to being fixed in 70%
ethanol containing 15 mM glycine, pH 2.0, for 20 min at
20°C. BrdU was immunolocalized in these fixed cell
cultures by using a mouse monoclonal antibody directed
against BrdU.
Results
pCAD-11 promotes the terminal differentiation and fusion
of JEG-3 cells: correlation with E-cad, cad-11, and
catenin expression levels
-Galactosidase activity in JEG-3 cells transfected with
placZ demonstrated that 70% of the cells had been trans-
fected with this expression vector construct (data not
shown).
We failed to detect cad-11 expression in JEG-3 cells
freshly transfected with pCAD-11 using Western blot anal-
ysis (Fig. 1), a finding which is consistent with our previous
observations in this choriocarcinoma cell line (MacCalman
et al., 1996, Getsios et al., 2001). Cad-11 expression was
first detected in JEG-3 cells after 12 h of transfection with
pCAD-11. There was a marked increase in cad-11 expressed
by the JEG-3 cells transfected with pCAD-11 after 24 h.
Cad-11 expression levels in these cell cultures remained
elevated until the termination of these studies at 36 h. The
increase in cad-11 expression in the cells transfected with
pCAD-11 was concomitant with a reduction in the expres-
sion levels of E-cad and the four catenin subtypes examined
in these studies, -, -, -catenin, and p120ctn. In contrast,
E-cad, but not cad-11, was readily detectable in the JEG-3
cells transfected with pRCAD-11 at all of the time points
examined in these studies (data not shown). Similarly, the
expression levels of -, -, -catenin, and p120ctn remained
relatively constant in JEG-3 cells transfected with
pRCAD-11 until the termination of these studies at 36 h.
Cad-11 immunostaining was not observed in JEG-3 cells
transfected with pRCAD-11 at any of the time points ex-
amined in these studies but was readily detectable in cul-
tures transfected with pCAD-11 for 24 and 36 h (Fig. 2).
Cad-11 expression was localized to areas of cell–cell con-
tact 24 h following transfection with pCAD-11 but was
distributed diffusely along the surface of the multinucleated
syncytium that subsequently formed in these cultures. In
contrast, E-cad was immunolocalized to areas of cell–cell
contact in JEG-3 cells transfected with pCAD-11 for 12 h
(Fig. 3). However, there was a marked and progressive
reduction in the intensity of E-cad immunostaining in cul-
tures of JEG-3 cells transfected with pCAD-11 until the
termination of these studies at 36 h. A similar cellular
distribution was observed for -catenin (Fig. 3) and the
three other catenins examined in these studies, -, -cate-
nin, and p120ctn (data not shown).
To confirm that the mononucleate JEG-3 cells trans-
fected with pCAD-11 were undergoing terminal differenti-
ation and fusion to form multinucleated syncytium, we
examined the distribution of desmoplakin in these cell cul-
tures. Desmoplakin is an obligate component of desmo-
Fig. 2. Immunolocalization of ectopic cad-11 in JEG-3 cells. Photomicro-
graphs of cad-11 expression in JEG-3 cells transfected with pRCAD-11
and cultured for 36 h (a) or pCAD-11 and cultured for 24 or 36 h (b and
c, respectively). The cells were fixed and immunostained with a mouse
monoclonal antibody directed against human cad-11 (113E). DAPI was
used to detect the nuclei in these fixed JEG-3 cell cultures.
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somal junctions and has been used as a marker to identify
cell boundaries in a wide variety of normal and malignant
epithelial cells in vitro, including human trophoblasts
(Douglas and King, 1990; Green and Gaudry, 2000). In
JEG-3 cells transfected with pCAD-11 for 12 h, desmo-
plakin was readily detectable at areas of cell–cell contact
(Fig. 4). However, there was marked reduction in desmo-
plakin immunoreactivity in mononucleate JEG-3 cells after
24 h of transfection with pCAD-11. Desmoplakin immuno-
staining was subsequently localized to the peripheral mem-
brane of multinucleated syncytium that formed in these cell
cultures. A similar expression pattern for desmoplakin has
been previously detected in cultures of villous cytotropho-
blasts undergoing terminal differentiation and fusion in
vitro (Douglas and King, 1990). In contrast, intense desmo-
plakin immunostaining was maintained in JEG-3 cells trans-
fected with pRCAD-11 until the termination of these studies
at 36 h.
The morphological effects of pCAD-11 on JEG-3 cells
cannot be mimicked by the exogenous expression of cad-6
To determine whether the exogenous expression of a
cadherin subtype, other than cad-11, could promote the
terminal differentiation and fusion of human trophoblastic
cells, JEG-3 cells were transfected with pCAD-11 or
pCAD-6 for 36 h. Cad-11 and desmoplakin immunostaining
confirmed the presence of multinucleated syncytium in the
JEG-3 cell cultures transfected with pCAD-11 (Fig. 5).
Although cad-6 was detected on the surface and in areas of
cell–cell contact in JEG-3 cells transfected with pCAD-6,
the expression of this cadherin subtype did not promote the
terminal differentiation and fusion of these trophoblastic
cells. Cad-6 expression was not detected in JEG-3 cells
transfected with pRCAD-6 (data not shown).
pCAD-11 reduces cellular proliferation and promotes the
biochemical differentiation of JEG-3 cells
The terminal differentiation and fusion of human tropho-
blastic cells in vitro and in vivo is associated with a reduc-
tion in cellular proliferation and an increase in the biosyn-
thesis of hCG (Kliman et al., 1986). In order to determine
the effects of ectopic cad-11 expression in JEG-3 cells on
these aspects of cellular differentiation, we examined the
levels of BrdU incorporation and hCG mRNA levels in
cells transfected with pCAD-11. There was a marked re-
duction in the level of BrdU incorporation in JEG-3 cells
transfected with pCAD-11 for 24 h (Fig. 6). In contrast, the
transfection of pRCAD-11 or placZ did not have a marked
effect on DNA synthesis in these cell cultures. Northern blot
analysis revealed a single hCG mRNA transcript (1.1 kb)
in all of the total RNA extracts prepared from the JEG-3 cell
cultures, consistent with previous observations in this cho-
riocarcinoma cell line (Burnside et al., 1985; Coutifaris et
al., 1991). There was a marked increase in the levels of the
hCG mRNA transcript present in JEG-3 cells transfected
with pCAD-11 for 36 h (Fig. 6). In contrast, the levels of the
mRNA transcript encoding this biochemical marker of tro-
phoblast differentiation remained relatively constant follow-
ing the transfection of pRCAD-11 or placZ into these cells.
OB-1 and OB-2 decrease cad-11 mRNA levels in human
granulosa-lutein cell cultures
In order to inhibit cad-11 expression in cultured cells, we
developed antisense oligonucleotides (OB-1 and OB-2)
complementary to the human cad-11 cDNA sequence. The
ability of these antisense oligonucleotides to reduce cad-11
mRNA levels was examined in human granulosa-lutein
cells, which express three classical cadherin subtypes (N-
cad, cad-6, and cad-11) but not E-cad (MacCalman et al.,
1997). A single cad-11 mRNA transcript (4.4 kb) was de-
tected in all of the total RNA extracts prepared from the
isolated granulosa-lutein cells. This mRNA transcript has
been previously observed in human granulosa-lutein, endo-
metrial, and trophoblastic cells (MacCalman et al., 1996,
1997). OB-1 decreased cad-11 mRNA levels in these pri-
mary cultures at all of the concentrations examined in these
studies (Fig. 7). In contrast, the steady-state levels of the
two major N-cad mRNA species (4.3 and 4.0 kb) and the
single cad-6 mRNA transcript (4.1 kb) remained relatively
constant in granulosa-lutein cells cultured in the presence of
this antisense oligonucleotide. The addition of the sense
oligonucleotide, OB-3, to the culture medium did not have
a marked effect on the levels of the mRNA transcripts
encoding the three cadherin subtypes present in human
granulosa-lutein cells at any of the concentrations examined
in these studies. Similar results were obtained by using
granulosa-lutein cells cultured in the presence of our alter-
native antisense oligonucleotide specific for cad-11, OB-2,
or the corresponding sense oligonucleotide, OB-4 (data not
shown).
OB-1 inhibits the terminal differentiation and fusion of
villous cytotrophoblasts isolated from human term
placentae
Western blot analysis demonstrated that villous cytotro-
phoblasts cultured in the presence of the antisense oligonu-
cleotide, OB-1 (5 M), failed to upregulate cad-11 expres-
sion levels at any of the time points examined in these
studies, although we consistently detected lower molecular
weight protein species in these cultures 72 h after treatment
(Fig. 7). E-cad expression has previously been shown to
decrease in isolated human villous cytotrophoblasts in a
time-dependent manner (Coutifaris et al., 1991; MacCalman
et al., 1996). Instead, the levels of E-cad expression re-
mained relatively constant in the primary cell cultures
treated with OB-1 until the termination of these studies at
72 h. There was, however, a marked reduction in E-cad
expression levels in villous cytotrophoblasts cultured in the
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Fig. 3. Immunolocalization of E-cad and -catenin in JEG-3 cells transfected with pCAD-11. Photomicrographs of E-cad and -catenin expression in JEG-3
cells transfected with pCAD-11 and cultured for 12, 24, or 36 h (a–c, respectively). The cells were fixed and immunostained with mouse monoclonal
antibodies directed against either human E-cad or -catenin.
presence of the sense oligonucleotide, OB-3 (5 M), for
72 h. In contrast, cad-11 expression levels continued to
increase in the trophoblastic cells cultured in the presence of
OB-3 until the termination of these studies at 72 h.
Villous cytotrophoblasts cultured in the presence of
OB-1 were capable of undergoing aggregation after 72 h of
culture (Fig. 7). E-cad expression was immunolocalized to
areas of cell–cell contact in these primary cultures, demon-
strating that these cellular aggregates were comprised of
mononucleate cytotrophoblasts. In contrast, there was a
marked reduction in E-cad immunostaining in the multinu-
cleated syncytium that formed in the trophoblastic cells
cultured in the presence of OB-3. E-cad expression was,
however, maintained in mononucleate cytotrophoblasts that
were in direct contact with the multinucleated syncytium in
these cultures at 72 h.
Discussion
The differential expression of E-cad and cad-11 during
the aggregation and subsequent fusion of villous cytotro-
phoblasts isolated from human term placentae suggests that
these two CAMs have distinct roles in this highly regulated
series of membrane-mediated events. Function-perturbing
antibodies directed against E-cad disrupted the aggregation
of mononucleate villous cytotrophoblasts isolated from the
human term placenta, which in turn inhibited the formation
of multinucleated syncytium in these cell cultures (Couti-
faris et al., 1991). Furthermore, villous cytotrophoblasts
cultured in the presence of herbimycin A, an inhibitor of
tyrosine kinase activity (Murakima et al., 1988), were ca-
pable of upregulating E-cad expression levels but failed
to undergo terminal differentiation and fusion (Rebut-
Fig. 4. Immunolocalization of desmoplakin in JEG-3 cells transfected with pCAD-11. Photomicrographs of desmoplakin expression in JEG-3 cells transfected
with pCAD-11 and cultured for 12, 24, or 36 h (a–c, respectively). The cells were fixed and immunostained with a rabbit polyclonal antibody directed against
desmoplakin (NW6), and the nuclei were visualized by using DAPI. A negative control in which JEG-3 cells were transfected with pRCAD-11 for 36 h is
shown in (d).
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Bonneton et al., 1993). Here, we demonstrate that E-cad
expression levels are maintained in villous cytotrophoblasts
cultured in the presence of antisense oligonucleotides spe-
cific for cad-11. These cells were capable of forming cel-
lular aggregates but did not undergo terminal differentiation
and fusion to form syncytium with time in culture. Collec-
tively, these observations suggest that E-cad mediates the
aggregation of mononucleate trophoblastic cells, whereas
cad-11 expression is required for the formation of multinu-
cleated syncytium in these primary cell cultures.
Further support for the hypothesis that cad-11 pro-
motes trophoblast differentiation and fusion in a highly
specific manner was obtained from JEG-3 choriocarci-
noma cells transfected with full-length cad-11 or cad-6
expression vectors. The ectopic expression of cad-11, but
not cad-6, in JEG-3 cells resulted in the formation of
multinucleated syncytium from the terminal differentia-
tion and fusion of these mononucleate trophoblastic cells.
The formation of multinucleated syncytium in JEG-3
cells transfected with pCAD-11 was associated with the
loss of E-cad expression in these cell cultures. Recent
studies have demonstrated cell-specific differences in the
ability of exogenous cadherins to regulate the expression
levels of endogenous cadherin subtypes. For example, the
introduction of a full-length N-cad cDNA into oral squa-
mous carcinoma cell lines resulted in a loss of endoge-
nous E-cad expression and induced a fibroblastic pheno-
type in these cell cultures (Islam et al., 1996). In contrast,
ectopic N-cad expression was shown to increase the mo-
tility and invasive capacity of breast cancer cell lines
without altering the levels of E-cad expression (Nieman
et al., 1999; Hazan et al., 2000). To date, the cellular
mechanisms that regulate the coordinate expression of
transfected full-length cadherin cDNAs with the endog-
Fig. 5. Immunolocalization of cad-6, cad-11, and desmoplakin in JEG-3 cells transfected with pCAD-6 or pCAD-11. Double-label immunofluorescence was
carried out for JEG-3 cells transfected with pCAD-11 (a–c, respectively) or pCAD-6 (d–f, respectively) for 36 h. The ectopic cadherin was detected by using
either a mouse monoclonal antibody directed against cad-11 (113E; a) or a goat polyclonal antibody directed against cad-6 (d). A rabbit polyclonal antibody
directed against desmoplakin (NW6) was used as a marker for cell–cell borders (b and e). DAPI was used to detect the nuclei in these JEG-3 cell cultures.
Dual color overlays are shown on the right (c and f).
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enous cadherin subtypes present in these different cell
types remain poorly defined.
The ectopic expression of both type 1 and type 2
cadherins has been shown to increase -catenin expres-
sion in several cell lines and is believed to result from the
stabilization of -catenin when it is complexed to the
exogenous cadherin subtype (Papkoff, 1997; Redfield et
al., 1997; Shimoyama et al., 2000). In contrast, the trans-
fection of a full-length cad-11 cDNA into JEG-3 cells
was associated with a loss of -catenin from the surface
of these cells. The cellular distribution and expression
levels of E-cad and -catenin in these transfected JEG-3
cell cultures correlate with those previously observed in
villous cytotrophoblasts undergoing terminal differentia-
tion and fusion in vitro (Getsios et al., 2000). Further-
more, -catenin was shown to interact with E-cad, but
not cad-11, in these primary cell cultures. In view of
these observations, it is tempting to speculate that cad-11
mediates the disassembly and/or downregulation of
E-cad/-catenin complexes in JEG-3 cells, resulting in
Fig. 6. Ectopic cad-11 expression promotes JEG-3 cell differentiation. (A) Cad-11 reduces cell proliferation in JEG-3 cells. Photomicrographs of BrdU
incorporation in JEG-3 cells transfected with placZ, pCAD-11, or pRCAD-11 for 24 h (a–c, respectively). The cells were fixed and immunostained with a
mouse monoclonal antibody directed against BrdU. (B) Ectopic cad-11 expression increases hCG mRNA levels in JEG-3 cells. Autoradiograms of a
Northern blot containing total RNA (20 g) extracted from untransfected JEG-3 cells (lane a) or JEG-3 cells transfected with placZ, pRCAD-11, or pCAD-11
and cultured for a further 36 h (lanes b–d, respectively). This blot was probed for hCG (upper panel) or 18S rRNA (lower panel).
Fig. 7. Antisense oligonucleotides specific for cad-11 inhibit the morphological differentiation of villous cytotrophoblasts isolated from the human term
placenta. (A) Autoradiograms of a Northern blot containing total RNA (20 g) extracted from human granulosa-lutein cells cultured in the presence of 0,
1, or 5 M of the antisense oligonucleotide OB-1 (lanes a, b, and d, respectively) or equal amounts of the corresponding sense oligonucleotide, OB-3 (lanes
c and e, respectively), for 24 h. This blot was probed for cad-11, N-cad, cad-6, or 18S rRNA. (B) Autoradiograms of Western blots containing protein (20
g) extracted from primary villous cytotrophoblasts cultured in the presence of either OB-1 or OB-3 (5 M) for 24, 48, or 72 h (lanes a–c, respectively).
Western blot analysis was performed by using mouse monoclonal antibodies directed against human E-cad or cad-11 (113H). (C) Photomicrographs of E-cad
expression in primary villous cytotrophoblasts cultured in the presence of either OB-1 or OB-3 (5 M) for 72 h. The cytotrophoblasts were fixed and
immunostained for human E-cad.
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the morphological differentiation of mononucleate tro-
phoblastic cells in vitro.
In general, it is believed that the adhesive strength of the
cadherins is regulated by the cytoplasmic domains of these
CAMs interacting with the catenins (Brieher et al., 1996;
Ozawa and Kemler, 1998). Cad-11/-catenin complexes,
which are capable of mediating aggregation and sorting
when cad-11 is transfected into fibroblastic L cells, have
also been detected in signet-cell carcinomas and invasive
breast cancer cell lines (Shibata et al., 1996; Pishvaian et al.,
1999). Furthermore, an alternative cad-11 mRNA transcript,
which contains a frame shift in the coding sequence, result-
ing in a truncated protein with a smaller transmembrane
domain and a different cytoplasmic domain, has been re-
ported in human cancer cells (Okazaki et al., 1994; Kashima
et al., 1999; Kawaguchi et al., 1999). The inability of this
truncated form of cad-11 to promote adhesion and aggre-
gation in transfected L cells has been attributed to the loss
of the -catenin binding region in the cytoplasmic domain
of this variant cadherin subtype. However, the transfection
of a truncated cad-11 cDNA construct lacking the -catenin
binding region into human mammary carcinoma cells has
been shown to promote adhesion and the formation of gap
junctions in these cell cultures (Braungart et al., 2001). In
addition, overexpression of a Xenopus cad-11 (Xcad-11)
construct lacking the -catenin binding site promotes adhe-
sion and is subsequently able to disrupt neural crest migra-
tion in Xenopus embryos in a manner similar to the full-
length Xcad-11 (Borchers et al., 2001). Finally, several
studies have demonstrated the ability of other cadherin
subtypes to mediate homophilic adhesion in the absence of
-catenin binding (Navarro et al., 1995; Kreft et al., 1997;
Lee et al., 1998; Ozawa and Kemler, 1998). Taken together,
these observations suggest that cad-11 can mediate adhesion
independent of -catenin.
-, -, and -catenin have been colocalized with E-cad
in both murine and human placental tissues (Ohsugi et al.,
1996; Getsios et al., 2001). In addition, the formation of
E-cad/-catenin complexes has been shown to be critical for
the development of this dynamic tissue (Torres et al., 1997).
Although -catenin is believed to be a key structural com-
ponent of these cadherin/complexes, the differentiation of
the trophectoderm does not appear to be affected in -cate-
nin null mutant mice (Haegel et al., 1995). The ability of
these null-mutant mouse embryos to progress beyond this
developmental stage has been attributed to an increase in the
expression levels and redistribution of -catenin within the
epithelial cells forming the trophectoderm. Instead of being
restricted to desmosomes, -catenin was immunolocalized
continuously along the basolateral membrane domain of the
trophoblastic cells of these null mutant mice (Fleming et al.,
1991; Haegel et al., 1995). Similarly, we have determined
that E-cad, , -, -catenin, and p120ctn are coexpressed in
human trophoblastic cells in vitro and in vivo (Getsios et al.,
2001). However, a switch from E-cad to cad-11 expression,
which results in the formation of multinucleated syncytium
from these mononucleate cells, is also concomitant with a
marked reduction in the expression levels of -, -, -cate-
nin and p120ctn. These observations indicate that cad-11/
catenin interactions may not be required to promote the
terminal differentiation and fusion of human trophoblastic
cells. To date, the molecular mechanism(s) by which cad-11
mediates these cellular events remain to be elucidated.
Previous studies have indicated that the cellular mecha-
nisms that regulate the biochemical differentiation of human
trophoblastic cells are distinct from those involved in the
formation of multinucleated syncytium in vitro (Kao et al.,
1992). For example, the intracellular secondary messenger,
cAMP, is capable of increasing hCG mRNA levels in
JEG-3 choriocarcinoma cells (Burnside et al., 1985) but
does not promote the formation of multinucleated syncy-
tium in these cultured cells (Coutifaris et al., 1991; Mac-
Calman et al., 1996). Similarly, the transfection of a full-
length connexin-26 cDNA into JEG-3 cells resulted in a
decrease in cellular proliferation and a concomitant increase
in hCG secretion with time in culture (Hellmann et al.,
1999). However, large multinucleated syncytial structures
were not observed in these transfected cell cultures. In
contrast, cad-11 was not only capable of promoting the
morphological differentiation of JEG-3 cells but reduced
cellular proliferation and increased the levels of the hCG
mRNA transcript present in these cultures.
In summary, we have determined that cad-11 is capable
of mediating the morphological and functional differentia-
tion of human cytotrophoblasts in vitro. Although the cel-
lular mechanism(s) by which cad-11 promotes the forma-
tion of multinucleated syncytium remain poorly understood,
our findings suggest that this developmental process in-
volves a coordinated downregulation in the expression lev-
els of E-cad and the cadherin-associated proteins, -, -,
-catenin, and p120ctn, in mononucleate trophoblastic cells.
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